90 related articles for article (PubMed ID: 24082018)
1. Influence of retirement on nonadherence to medication for hypertension and diabetes.
Kivimäki M; Batty GD; Hamer M; Nabi H; Korhonen M; Huupponen R; Pentti J; Oksanen T; Kawachi I; Virtanen M; Westerlund H; Vahtera J
CMAJ; 2013 Nov; 185(17):E784-90. PubMed ID: 24082018
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive and Lipid-Lowering Medication Adherence in Young Adults With Youth-Onset Type 2 Diabetes.
Weinstock RS; Trief PM; Burke BK; Wen H; Liu X; Kalichman S; Anderson BJ; Bulger JD
JAMA Netw Open; 2023 Oct; 6(10):e2336964. PubMed ID: 37792373
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic factors associated with poor medication adherence in patients with type 2 diabetes.
Ekenberg M; Qvarnström M; Sundström A; Martinell M; Wettermark B
Eur J Clin Pharmacol; 2024 Jan; 80(1):53-63. PubMed ID: 37870618
[TBL] [Abstract][Full Text] [Related]
4. Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation.
Jensen ML; Jørgensen ME; Hansen EH; Aagaard L; Carstensen B
PLoS One; 2017; 12(6):e0179546. PubMed ID: 28665996
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Prescription Medication Cost Coverage on Oral Medication Use for Hypertension and Type 2 Diabetes Mellitus.
Amoud R; Grindrod K; Cooke M; Alsabbagh MW
Healthc Policy; 2020 Nov; 16(2):82-100. PubMed ID: 33337316
[TBL] [Abstract][Full Text] [Related]
6. Medication adherence and associated factors in newly diagnosed hypertensive patients in Japan: the LIFE study.
Sagara K; Goto K; Maeda M; Murata F; Fukuda H
J Hypertens; 2024 Apr; 42(4):718-726. PubMed ID: 38230627
[TBL] [Abstract][Full Text] [Related]
7. Low medication adherence is associated with decline in health-related quality of life: results of a longitudinal analysis among older women and men with hypertension.
Peacock E; Joyce C; Craig LS; Lenane Z; Holt EW; Muntner P; Krousel-Wood M
J Hypertens; 2021 Jan; 39(1):153-161. PubMed ID: 32675745
[TBL] [Abstract][Full Text] [Related]
8. Modifiable Factors Associated with Non-adherence to Antihypertensive or Antihyperlipidemic Drugs Are Dissimilar: a Multicenter Study Among Patients with Diabetes in Indonesia.
Alfian SD; Annisa N; Fajriansyah F; Perwitasari DA; Abdulah R; Hak E; Denig P
J Gen Intern Med; 2020 Oct; 35(10):2897-2906. PubMed ID: 32301043
[TBL] [Abstract][Full Text] [Related]
9. Lower prevalence of hypertension, hypercholesterolemia, and diabetes in marathoners.
Williams PT
Med Sci Sports Exerc; 2009 Mar; 41(3):523-9. PubMed ID: 19204599
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with poor adherence to medication in patients with diabetes and hypertension in Peru: findings from a pooled analysis of six years of population-based surveys.
Calderon-Ramirez PM; Huamani-Merma E; Mirano-Ortiz-de-Orue MG; Fernandez-Guzman D; Toro-Huamanchumo CJ
Public Health; 2024 Jun; 231():108-115. PubMed ID: 38653015
[TBL] [Abstract][Full Text] [Related]
11. Defining Meaningful Change in Antihypertensive Medication Adherence in Adults with Established Hypertension: Implications for Clinical Practice.
Peacock E; Muntner P; Craig LS; Silver J; Mills KT; Chen J; Shi L; Whelton PK; He J; Krousel-Wood M
Med Clin North Am; 2023 Nov; 107(6S):e39-e52. PubMed ID: 38609280
[TBL] [Abstract][Full Text] [Related]
12. A comparison of methods for the measurement of adherence to antihypertensive multidrug therapy and the clinical consequences: a retrospective cohort study using the Korean nationwide claims database.
Jung M; Choo E; Lee S
Epidemiol Health; 2023; 45():e2023050. PubMed ID: 37139667
[TBL] [Abstract][Full Text] [Related]
13. Initiation of Antihypertensive Medication from Midlife on Incident Dementia: The Health and Retirement Study.
Wei J; Xu H; Zhang D; Tang H; Wang T; Steck SE; Divers J; Zhang J; Merchant AT
J Alzheimers Dis; 2023; 94(4):1431-1441. PubMed ID: 37424471
[TBL] [Abstract][Full Text] [Related]
14. Adherence treatment factors in hypertensive African American women.
Fongwa MN; Evangelista LS; Hays RD; Martins DS; Elashoff D; Cowan MJ; Morisky DE
Vasc Health Risk Manag; 2008; 4(1):157-66. PubMed ID: 18629350
[TBL] [Abstract][Full Text] [Related]
15. Symptoms of depression and anxiety and adherence to antihypertensive medication.
Bautista LE; Vera-Cala LM; Colombo C; Smith P
Am J Hypertens; 2012 Apr; 25(4):505-11. PubMed ID: 22258334
[TBL] [Abstract][Full Text] [Related]
16. A global systematic overview of socioeconomic factors associated with antidiabetic medication adherence in individuals with type 2 diabetes.
Studer CM; Linder M; Pazzagli L
J Health Popul Nutr; 2023 Nov; 42(1):122. PubMed ID: 37936205
[TBL] [Abstract][Full Text] [Related]
17. Multilevel Analysis of the Relationship Between Prescribing Institutions and Medication Adherence Among Patients With Hypertension and Diabetes in Korea.
Ghang H; Lee J
J Prev Med Public Health; 2023 Nov; 56(6):504-514. PubMed ID: 37817606
[TBL] [Abstract][Full Text] [Related]
18. A comparison of adherence to hypoglycemic medications between Type 2 diabetes patients with and without serious mental illness.
Kreyenbuhl J; Leith J; Medoff DR; Fang L; Dickerson FB; Brown CH; Goldberg RW; Potts W; Dixon LB
Psychiatry Res; 2011 Jun; 188(1):109-14. PubMed ID: 21459458
[TBL] [Abstract][Full Text] [Related]
19. Physician and patient adherence in hypertension trials: a point of view on an important issue to resolve.
Burnier M
Expert Rev Pharmacoecon Outcomes Res; 2024 Jul; 24(6):749-758. PubMed ID: 38836304
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting follow-up non-attendance in patients with Type 2 diabetes mellitus and hypertension: a systematic review.
Lee RRS; Samsudin MI; Thirumoorthy T; Low LL; Kwan YH
Singapore Med J; 2019 May; 60(5):216-223. PubMed ID: 31187148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
